Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes
CONCLUSION: Treatment with postauricular injection of methylprednisolone sodium succinate has shown better therapeutic recovery in patients with sudden deafness, improved pure-tone hearing threshold, reduced risk of blood glucose elevation, and improved clinical outcomes for patients with sudden deafness, providing some reference for the treatment of patients with sudden deafness.PMID:35912152 | PMC:PMC9337928 | DOI:10.1155/2022/3097436
Source: Computational and Mathematical Methods in Medicine - Category: Statistics Authors: Zhenbo Zhong Xiaofei Wang Kairui Xu Jing Tao Source Type: research
More News: A-Methapred | Audiology | Audiometry | Deafness | Diabetes | Diabetes Type 2 | Diets | Endocrinology | Environmental Health | Methylprednisolone | Nutrition | Psychology | Sodium | Statistics | Study